HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Most, H. Articles by Scheinesson, G. P. Search for Related Content PubMed PubMed Citation Articles by Most, H. Articles by Scheinesson, G. P.

Yomesan (Niclosamide) Therapy of Hymenolepis Nana Infections^*

Yomesan—N-(2'-chlor-4'-nitrophenyl)-5 chlorsalicylamid—was ineffective in 10 children with Hymenolepis nana infections who were treated with a single dose of 100 mg per kg of body weight. On the other hand, at least 90% of 62 children who received 40 to 80 mg per kg per day for 5 days were cured as evidenced by negative stool examinations performed weekly or biweekly for 10 to 12 weeks after treatment. Nine untreated children used as controls and similarly examined remained positive throughout the observation period. No objective signs of intolerance or toxicity were noted. In view of the world-wide reports of the efficacy and safety of Yomesan (niclosamide) in the treatment of Taenia infections and its extensive use in many parts of the world, we suggest that this drug be made available in the United States.

Accepted for publication August 10, 1970.

^* Please address requests for reprints to Dr. Harry Most, 550 First Avenue, New York, New York 10016.